Related Experiment Video
Updated: Jan 5, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
E3 ligase RCHY1 negatively regulates HDAC2
Mina Choi1, Yeong Min Choi2, In-Sook An2
1Research Institute for Molecular-Targeted Drugs, Department of Cosmetics Engineering, Konkuk University, Seoul, 05029, South Korea.
Abstract:
HDAC2, one of the class I histone deacetylase regulates epigenetic landscape through histone modification. Because HDAC2 is overexpressed in many cancers, cancer therapeutics against HDAC2 have been developed. Here we show novel mechanism of HDAC2 regulation by E3 ligase RCHY1. We found inverse correlation RCHY1 and HDAC2 levels in tumor tissue from six independent dataset using meta-analysis. Ectopic expression of RCHY1 decreased the level of HDAC2 from cancer cells including p53 wildtype, mutant and null cells. In addition, HDAC2 was increased by RCHY1 knockdown. RCHY1 directly interacts with HDAC2. Ectopic expression of wild type but not RING mutant RCHY1 increased HDAC2 levels. These data provide an evidence that RCHY1 negatively regulates HDAC2.
Insights
The E3 ligase RCHY1 negatively regulates Histone Deacetylase 2 (HDAC2) levels in cancer cells. This discovery reveals a new mechanism for controlling HDAC2, a target in cancer therapeutics.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Histone Deacetylase 2 (HDAC2), a class I histone deacetylase, regulates the epigenetic landscape via histone modification.
- Overexpression of HDAC2 is observed in numerous cancers, driving the development of HDAC2-targeted cancer therapeutics.
Purpose of the Study:
- To elucidate a novel regulatory mechanism for HDAC2.
- To investigate the role of the E3 ligase RCHY1 in controlling HDAC2 expression and function.
Main Methods:
- Meta-analysis of six independent tumor tissue datasets to assess the correlation between RCHY1 and HDAC2 levels.
- In vitro experiments involving ectopic expression and knockdown of RCHY1 in various cancer cell lines (p53 wildtype, mutant, and null).
- Co-immunoprecipitation assays to determine direct interaction between RCHY1 and HDAC2.
Main Results:
- A significant inverse correlation was identified between RCHY1 and HDAC2 levels in tumor tissues across multiple datasets.
- Ectopic expression of RCHY1 led to decreased HDAC2 levels in cancer cells, while RCHY1 knockdown resulted in increased HDAC2 levels.
- Direct physical interaction between RCHY1 and HDAC2 was confirmed, with the RING domain of RCHY1 being crucial for this interaction and subsequent HDAC2 regulation.
Conclusions:
- RCHY1 acts as a negative regulator of HDAC2.
- The findings present a novel mechanism of HDAC2 regulation mediated by the E3 ligase RCHY1.
- This regulatory axis may offer new therapeutic strategies targeting HDAC2 in cancer.
Related Concept Videos
Euchromatin
Euchromatin is the less dense region of the chromatin and stains lighter. Euchromatin contains histone H3 extensively...
Spreading of Chromatin Modifications
Writers
The writer...
Negative Regulator Molecules
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...

